Scott A. Lang - 21 May 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Role: President and CEO, Director
Signature: s/ Gena L. Ashe, Attorney-in-Fact
Issuer symbol: ATEX
Transactions as of: 21 May 2025
Net transactions value: $0
Form type: 4
Filing time: 23 May 2025, 14:27:54 UTC
Previous filing: 24 Jan 2025
Next filing: 19 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lang Scott A.	President and CEO, Director	3 GARRET MOUNTAIN PLAZA, SUITE 401, WOODLAND PARK	s/ Gena L. Ashe, Attorney-in-Fact	23 May 2025	0001571601

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATEX	Stock Option (Right to Buy)	Award	$0	+223,546		$0.000000	223,546	21 May 2025	Common Stock	223,546	$34.96	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 21, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.